Recent advances on drug development and emerging therapeutic agents for Alzheimer’s disease

Alzheimer’s disease (AD) is a neurodegenerative old age disease that is complex, multifactorial, unalterable, and progressive in nature. The currently approved therapy includes cholinesterase inhibitors, NMDA-receptor antagonists and their combination therapy provides only temporary symptomatic reli...

Descripción completa

Detalles Bibliográficos
Autores principales: Athar, Teeba, Al Balushi, K., Khan, Shah Alam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236749/
https://www.ncbi.nlm.nih.gov/pubmed/34181171
http://dx.doi.org/10.1007/s11033-021-06512-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236749/
https://www.ncbi.nlm.nih.gov/pubmed/34181171
http://dx.doi.org/10.1007/s11033-021-06512-9

Ejemplares similares